The global zinc finger nuclease technology market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for gene editing in biotechnology companies, pharmaceutical companies, hospital laboratories and diagnostic laboratories, academic and research institutes.
The global zinc finger nuclease technology market is segmented on the basis of type into cell line engineering, animal genetic engineering and plant genetic engineering. The cell line engineering segment accounted for the largest share in 2018 owing to its wide application in biotechnology companies and pharmaceutical companies. The animal genetic engineering segment is expected to grow at a CAGR of 13% during the forecast period owing to its wide application in academic and research institutes as well as hospitals laboratories and diagnostic laboratories.
Some Of The Growth Factors Of This Market:
- Zinc finger nucleases are a type of gene editing technology that can be used to modify DNA sequences in living cells.
- The technology is being used to treat genetic diseases, such as sickle cell anemia and cystic fibrosis, by replacing the mutated gene with a healthy one.
- Zinc finger nucleases are also being used to create genetically modified crops that are resistant to pests and drought.
- The market for zinc finger nucleases is expected to grow rapidly over the next decade due to their potential use in treating cancer.
Industry Growth Insights published a new data on “Zinc Finger Nuclease Technology Market”. The research report is titled “Zinc Finger Nuclease Technology Market research by Types (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Other), By Applications (Biotechnology Companies, Pharmaceutical Companies, Hospital Laboratory and Diagnostic Laboratory, Academic and Research Institutes, Others), By Players/Companies Sigma-Aldrich, Sangamo Therapeutics, Labomics, Thermo Fisher Scientific, Gilead”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Zinc Finger Nuclease Technology Market Research Report
By Type
Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Other
By Application
Biotechnology Companies, Pharmaceutical Companies, Hospital Laboratory and Diagnostic Laboratory, Academic and Research Institutes, Others
By Companies
Sigma-Aldrich, Sangamo Therapeutics, Labomics, Thermo Fisher Scientific, Gilead
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Zinc Finger Nuclease Technology Market Report Segments:
The global Zinc Finger Nuclease Technology market is segmented on the basis of:
Types
Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology Companies, Pharmaceutical Companies, Hospital Laboratory and Diagnostic Laboratory, Academic and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sigma-Aldrich
- Sangamo Therapeutics
- Labomics
- Thermo Fisher Scientific
- Gilead
Highlights of The Zinc Finger Nuclease Technology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Other
- By Application:
- Biotechnology Companies
- Pharmaceutical Companies
- Hospital Laboratory and Diagnostic Laboratory
- Academic and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Zinc Finger Nuclease Technology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Zinc finger nuclease technology is a method of DNA sequencing that uses the binding of a zinc ion to specific nucleotides in the DNA sequence as an identifier.
Some of the major companies in the zinc finger nuclease technology market are Sigma-Aldrich, Sangamo Therapeutics, Labomics, Thermo Fisher Scientific, Gilead.
The zinc finger nuclease technology market is expected to register a CAGR of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Zinc Finger Nuclease Technology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Zinc Finger Nuclease Technology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Zinc Finger Nuclease Technology Market - Supply Chain
4.5. Global Zinc Finger Nuclease Technology Market Forecast
4.5.1. Zinc Finger Nuclease Technology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Zinc Finger Nuclease Technology Market Size (000 Units) and Y-o-Y Growth
4.5.3. Zinc Finger Nuclease Technology Market Absolute $ Opportunity
5. Global Zinc Finger Nuclease Technology Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Zinc Finger Nuclease Technology Market Size and Volume Forecast by Type
5.3.1. Cell Line Engineering
5.3.2. Animal Genetic Engineering
5.3.3. Plant Genetic Engineering
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Zinc Finger Nuclease Technology Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Zinc Finger Nuclease Technology Market Size and Volume Forecast by Application
6.3.1. Biotechnology Companies
6.3.2. Pharmaceutical Companies
6.3.3. Hospital Laboratory and Diagnostic Laboratory
6.3.4. Academic and Research Institutes
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Zinc Finger Nuclease Technology Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Zinc Finger Nuclease Technology Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Zinc Finger Nuclease Technology Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Zinc Finger Nuclease Technology Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Zinc Finger Nuclease Technology Demand Share Forecast, 2019-2026
9. North America Zinc Finger Nuclease Technology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Zinc Finger Nuclease Technology Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Zinc Finger Nuclease Technology Market Size and Volume Forecast by Application
9.4.1. Biotechnology Companies
9.4.2. Pharmaceutical Companies
9.4.3. Hospital Laboratory and Diagnostic Laboratory
9.4.4. Academic and Research Institutes
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Zinc Finger Nuclease Technology Market Size and Volume Forecast by Type
9.7.1. Cell Line Engineering
9.7.2. Animal Genetic Engineering
9.7.3. Plant Genetic Engineering
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Zinc Finger Nuclease Technology Demand Share Forecast, 2019-2026
10. Latin America Zinc Finger Nuclease Technology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Zinc Finger Nuclease Technology Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Zinc Finger Nuclease Technology Market Size and Volume Forecast by Application
10.4.1. Biotechnology Companies
10.4.2. Pharmaceutical Companies
10.4.3. Hospital Laboratory and Diagnostic Laboratory
10.4.4. Academic and Research Institutes
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Zinc Finger Nuclease Technology Market Size and Volume Forecast by Type
10.7.1. Cell Line Engineering
10.7.2. Animal Genetic Engineering
10.7.3. Plant Genetic Engineering
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Zinc Finger Nuclease Technology Demand Share Forecast, 2019-2026
11. Europe Zinc Finger Nuclease Technology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Zinc Finger Nuclease Technology Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Zinc Finger Nuclease Technology Market Size and Volume Forecast by Application
11.4.1. Biotechnology Companies
11.4.2. Pharmaceutical Companies
11.4.3. Hospital Laboratory and Diagnostic Laboratory
11.4.4. Academic and Research Institutes
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Zinc Finger NucleaseTechnology Market Size and Volume Forecast by Type
11.7.1. Cell Line Engineering
11.7.2. Animal Genetic Engineering
11.7.3. Plant Genetic Engineering
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Zinc Finger Nuclease Technology Demand Share, 2019-2026
12. Asia Pacific Zinc Finger Nuclease Technology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Zinc Finger Nuclease Technology Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Zinc Finger Nuclease Technology Market Size and Volume Forecast by Application
12.4.1. Biotechnology Companies
12.4.2. Pharmaceutical Companies
12.4.3. Hospital Laboratory and Diagnostic Laboratory
12.4.4. Academic and Research Institutes
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Zinc Finger Nuclease Technology Market Size and Volume Forecast by Type
12.7.1. Cell Line Engineering
12.7.2. Animal Genetic Engineering
12.7.3. Plant Genetic Engineering
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Zinc Finger Nuclease Technology Demand Share, 2019-2026
13. Middle East & Africa Zinc Finger Nuclease Technology Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Zinc Finger Nuclease Technology Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Zinc Finger Nuclease Technology Market Size and Volume Forecast by Application
13.4.1. Biotechnology Companies
13.4.2. Pharmaceutical Companies
13.4.3. Hospital Laboratory and Diagnostic Laboratory
13.4.4. Academic and Research Institutes
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Zinc Finger Nuclease Technology Market Size and Volume Forecast by Type
13.7.1. Cell Line Engineering
13.7.2. Animal Genetic Engineering
13.7.3. Plant Genetic Engineering
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Zinc Finger Nuclease Technology Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Zinc Finger Nuclease Technology Market: Market Share Analysis
14.2. Zinc Finger Nuclease Technology Distributors and Customers
14.3. Zinc Finger Nuclease Technology Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sigma-Aldrich
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sangamo Therapeutics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Labomics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Gilead
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
